Rinol Alaj

Rinol Alaj is a seasoned professional with 15 years of experience in the startup and pharma industries, specializing in integrated Innovation, design thinking, digital endpoint, and clinical operation. He is known for his transformative leadership in building eCOA organizations. Rinol holds a Master of Public Health with a focus on Epidemiology and Biostatistics, an MBA with a concentration in Management Information Systems, an MS in Computer Science specializing in Database, Data Mining, and eKnowledge, as well as a BA in Computer Science.

In his career, Rinol has held key positions at reputable organizations, including Senior Director and Head of Clinical Outcomes Assessment & Patient Innovation at Regeneron, where he played a pivotal role in shaping the clinical trial management landscape. Previously, Rinol served as the Director, Head of Clinical Outcomes Assessment & Patient Innovation at Regeneron and in various leadership roles at Merck, Celgene, Covance, and Schering-Plough Research Institute. His expertise lies in leading teams, driving innovation, and integrating patient-centric solutions within clinical operations.